查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
生物制药塑料市场 - 2018-2028 年全球行业规模、份额、趋势、机会和预测，按聚合物类型（聚氯乙烯、聚对苯二甲酸乙二酯、聚丙烯、其他）、应用、地区和竞争情况细分
市场调查报告书
商品编码
1309872

生物制药塑料市场 - 2018-2028 年全球行业规模、份额、趋势、机会和预测，按聚合物类型（聚氯乙烯、聚对苯二甲酸乙二酯、聚丙烯、其他）、应用、地区和竞争情况细分

Biopharma Plastics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Polymer Type (Polyvinyl Chloride, Polyethylene Terephthalate, Polypropylene, Others), By Application, By Region, and Competition
出版日期: | 出版商: TechSci Research | 英文 115 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

由于医疗保健行业的需求不断增长，预计到 2028 年，生物制药塑料市场将大幅扩张。2020 年，印度医疗保健行业的产值约为 2800 亿美元。

医疗保健领域持续的技术进步

利用纳米颗粒控制药物释放和靶向给药的系统被称为纳米给药系统。这些都是治疗微生物、心血管、炎症、自身免疫和癌症疾病的新兴技术。由于纳米技术具有特定部位和靶向给药能力，治疗心血管疾病（CVDs）等慢性疾病变得更加容易。为防止这些药物受到环境影响，生产了特殊类型的包装套件。

例如，根据 ETHealthWorld 的报道，纳米技术将塑造医疗保健的未来。

因此，医疗保健设施的增加和技术的进步将推动未来几年的市场增长。

注射器适用性主导市场

注射器是一种重要的医疗产品，用于注射和抽取体内液体。预灌封注射器使用方便、成本低、微生物污染少、注射错误率低、稀释错误率低，因此市场对其的需求不断增加。预灌封注射器减少了注射步骤，提高了剂量的准确性，降低了受伤和交叉感染的风险。

此外，预灌封注射器现已成为药物生命周期中的一个常见组成部分，早在药物开发过程的第二阶段就已被纳入考虑范围。

例如，根据《药物开发与交付》杂志的报道，预灌封注射器和自动注射器的生产重点是满足患者的需求，提供各种肠外用药量，并允许不同的给药方案。

因此，对预灌封注射器的日益关注将促进全球生物制药塑料市场在预测期内的增长。

聚氯乙烯（PVC）将成为主要聚合物类型。

聚氯乙烯之所以在市场上用途广泛，是因为它能够承受各种操作而不会断裂或开裂。由于聚氯乙烯具有柔韧性、抗紫外线和耐化学性，并可随时承受高温，因此是制造注射器、一次性连接件、深度过滤器和其他生物制药塑料产品的理想材料。除了具有出色的机械性能外，它们还具有抗氧化能力、同时具有透汽性的憎水性和防水性。因此，这种产品具有持久性、可持续性和成本效益，从而增加了生物制药塑料在医疗保健行业防护服中的使用。

例如，根据 MPN 的数据，2021 年，聚氯乙烯是一次性医疗器械（如袋子、管道、口罩和其他处置装置）中使用最多的聚合物。

此外，聚四氟乙烯和聚乙烯因其耐用性、光泽度和耐洗涤剂性等特性而被广泛应用。

因此，上述因素可能会在预测期内促进市场增长。

最新动态

  • 2022 年 11 月，Avantor 公司在爱尔兰都柏林开设了新的分销中心，为生物制药市场提供支持。
  • 2022 年 11 月，苏威与法国初创企业 Ostiumin 签署谅解备忘录，以实现以玻璃纤维增强模塑的报废一次性外科手术器械的机械回收。
  • 2022 年 9 月，韩华解决方案公司开始在韩国丽水使用利安德巴塞尔 Lupotech T 高压聚乙烯技术。
  • 2022 年 7 月，杜邦公司在南卡罗来纳州库珀河基地开设了医疗保健解决方案制造工厂DuPont Liveo。

可定制

TechSci Research 可根据给定的市场数据，按照公司的具体需求提供定制服务。报告可提供以下定制选项：

公司信息

  • 其他市场参与者（最多五家）的详细分析和概况。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 覆盖市场
    • 研究年份
    • 主要市场细分

第 2 章：研究方法

  • 研究目的
  • 基准方法
  • 主要行业合作伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概述
  • 主要市场细分概述
  • 主要市场参与者概述
  • 主要地区/国家概述
  • 市场驱动因素、挑战和趋势概述

第4章：客户之声

第 5 章 : 全球生物制药塑料市场展望

  • 市场规模和预测
    • 按价值和数量
  • 市场份额与预测
    • 按聚合物类型（聚氯乙烯（PVC）、聚对苯二甲酸乙二酯（PET）、聚丙烯（PP）及其他）
    • 按应用（防护服、容器、生物反应器袋、注射器及其他）
    • 按地区（北美、欧洲、亚太地区、南美、中东和非洲）
    • 按公司（2022 年）
  • 市场地图
    • 按聚合物类型
    • 按应用
    • 按地区

第 6 章：北美生物制药塑料市场展望

  • 市场规模与预测
    • 按价值和数量
  • 市场份额与预测
    • 按聚合物类型
    • 按应用
    • 按国家
  • 定价分析
  • 北美洲：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第 7 章：欧洲生物制药塑料市场展望

  • 市场规模与预测
    • 按价值和数量
  • 市场份额与预测
    • 按聚合物类型
    • 按应用
    • 按国家
  • 定价分析
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 西班牙
    • 意大利

第 8 章：亚太地区生物制药塑料市场展望

  • 市场规模和预测
    • 按价值和数量
  • 市场份额与预测
    • 按聚合物类型
    • 按应用
    • 按国家
  • 定价分析
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 印尼

第9章：南美洲生物制药塑料市场展望

  • 市场规模与预测
    • 按价值和数量
  • 市场份额与预测
    • 按聚合物类型
    • 按应用
    • 按国家
  • 定价分析
  • 南美洲：国家分析
    • 巴西
    • 阿根廷

第 10 章：中东和非洲生物制药塑料市场展望

  • 市场规模与预测
    • 按价值和数量
  • 市场份额与预测
    • 按聚合物类型
    • 按应用
    • 按国家
  • 定价分析
  • 中东和非洲：国家分析
    • 南非生物制药塑料
    • 沙特阿拉伯生物制药塑料
    • 阿联酋生物制药塑料

第 11 章 ：市场动态

  • 驱动因素
    • 医疗保健支出增加
    • 癌症患者人数增加
    • 医疗保健技术进步
  • 挑战
    • 原材料价格波动
    • 严格的政府法规

第 12 章 ：市场趋势与发展

  • 产品上市
  • 合併与收购
  • 技术进步

第 13 章 ：全球生物制药塑料市场：SWOT 分析

第14章：波特五力分析法

  • 行业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代品的威胁

第 15 章 ：竞争格局

  • 业务概述
  • 产品类型
  • 近期发展
  • 财务状况（上市公司）
  • 主要人员
  • SWOT 分析
    • BASF SE
    • Spectrum Plastics Group
    • Celanese Corporation
    • LyondellBasell Industries Holdings B.V.
    • DuPont de Nemours, Inc.
    • Tekni-Plex, Inc.
    • Solvay S.A.
    • Avantor, Inc.
    • Bormioli Pharma S.p.A.
    • Saudi Basic Industries Corporation

第 16 章 ：战略建议

简介目录
Product Code: 14963

Biopharma Plastics Market is anticipated to expand significantly through 2028 due to the growing demand from the healthcare sector. In 2020, India's healthcare sector was worth about USD 280 billion.

Due to their features, such as low chemical reactivity, thermal stability, and high resistivity, biopharma plastics are widely used in the production of several healthcare products, including protective clothing, containers, syringes, disposable connections, and bioreactor bags. Moreover, factors, including rising global healthcare costs and an increase in the number of cancer cases worldwide, therefore surge the demand for singe use plastic in the production of containers, syringes, and others, leading to the growth of Global Biopharma Plastics Market in the projected period.

Ongoing Technological Advancement in Healthcare

Systems for the controlled release and targeted delivery of medicinal drugs using nanoparticles are known as nano-drug delivery systems. These are brand-new yet emerging technologies for treating microbiological, cardiovascular, inflammatory, autoimmune, and cancerous disorders. Due to the site-specific and target-oriented medication delivery capabilities of nanotechnology, treating chronic illnesses like cardiovascular diseases (CVDs) is made much easier. The special type of packaging kits is manufactured in the prevention of these drugs from the environment.

For instance, according to the ETHealthWorld, Nanotechnology is poised to shape the future of healthcare, and The space where nanotechnology meets healthcare is called nanomedicine.

Therefore, an increase in healthcare facilities and advancement in technology anticipates market growth in the upcoming years.

Syringe Applicability Dominates the Market

For injecting & withdrawing liquid from the body, syringes are a prominent healthcare product. The increase in demand for prefilled syringes is due to their ease of use, low cost, minimum microbiological contamination, low injection mistakes, and low dilution errors. Pre-filled syringes reduce the number of steps for injection, offer higher dose accuracy, and lower the risk of injury and cross-contamination.

Moreover, Pre-filled syringes are now a commonplace component of the medication life cycle and are frequently taken into consideration as early as Phase II of the drug development process.

For Instance, according to Drug Development & Delivery, Prefilled syringes and autoinjectors are manufactured focusing on the needs of the patient by providing a variety of parenteral medication quantities and allowing variable dosing regimens.

Thus, the increasing focus on prefilled syringes will lead to the growth of the Global Biopharma Plastic Market in the forecast period.

Polyvinyl chloride (PVC) will be the Key Polymer Type.

The versatility of polyvinyl chloride in the market is due to its capacity to withstand a variety of operations without breaking or cracking. It is ideal for creating syringes, disposable connections, depth filters, and other biopharma plastic products since it is flexible, UV and chemical resistant, and can readily manage high temperatures. Along with having outstanding mechanical properties, they have oxidation resistance capacity, water repellency with simultaneous vapor permeability, and water repellency. As a result, the product is long-lasting, sustainable, and cost-effective, which has increased the use of biopharma plastics in protective wear in the healthcare sector.

For instance, in 2021, according to MPN, PVC was the most used polymer for single-use medical devices such as bags, tubing, masks, and other disposal devices.

In addition, polytetrafluoroethylene and polyethylene are used in various applications due to their properties, such as durability, gloss, and detergent resistance.

Therefore, the aforementioned factors are likely to boost market growth over the forecast period.

Recent Developments

  • In November 2022, Avantor Inc. opened New Distribution Center in Dublin, Ireland, to support the Biopharma market.
  • Solvay signed MOUs with French start-up Ostiumin to enable the mechanical recycling of end-of-life single-use surgical instruments molded in glass-fiber reinforced in November 2022.
  • In September 2022, Hanwha Solutions Corporation started using the LyondellBasell Lupotech T high-pressure polyethylene technology in Yeosu, South Korea.
  • DuPont Liveo, a healthcare solutions manufacturing facility started at the Cooper River Site in South Carolina, opened by DuPont in July 2022.

Market Segmentation

Global Biopharma Plastics Market is segmented based on polymer type, application, and region. Based on the polymer type, the market is fragmented into polyvinyl chloride (PVC), polyethylene terephthalate (PET), polypropylene (PP), and others. Based on the application, the market is segmented into protective wear, containers, bioreactor bags, syringes, and others. Based on region, the market is divided into North America, Europe, Asia Pacific, South America, Middle East & Africa, By Company.

Market Players

BASF SE, Spectrum Plastics Group, Celanese Corporation, LyondellBasell Industries Holdings B.V., DuPont de Nemours, Inc., Tekni-Plex, Inc., Solvay S.A., Avantor, Inc., Bormioli Pharma S.p.A., Saudi Basic Industries Corporation are some of the key players of Global Biopharma Plastics Market.

Report Scope

In this report, Global Biopharma Plastics market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Biopharma Plastics Market, By Polymer Type:

  • Polyvinyl Chloride (PVC)
  • Polyethylene Terephthalate (PET)
  • Polypropylene (PP)
  • Others

Biopharma Plastics Market, By Application:

  • Protective Wear
  • Containers
  • Bioreactor Bags
  • Syringes
  • Others

Biopharma Plastics Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Spain
    • Italy
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Indonesia
  • South America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive landscape

Company Profiles: Detailed analysis of the major companies present in Global Biopharma Plastics market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biopharma Plastics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Polymer Type (Polyvinyl Chloride (PVC), Polyethylene Terephthalate (PET), Polypropylene (PP), Others)
    • 5.2.2. By Application (Protective Wear, Containers, Bioreactor Bags, Syringes, Others)
    • 5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.4. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Polymer Type
    • 5.3.2. By Application
    • 5.3.3. By Region

6. North America Biopharma Plastics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Polymer Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. Pricing Analysis
  • 6.4. North America: Country Analysis
    • 6.4.1. United States Biopharma Plastics Market Outlook
      • 6.4.1.1. Market Size & Forecast
        • 6.4.1.1.1. By Value & Volume
      • 6.4.1.2. Market Share & Forecast
        • 6.4.1.2.1. By Polymer Type
        • 6.4.1.2.2. By Application
    • 6.4.2. Mexico Biopharma Plastics Market Outlook
      • 6.4.2.1. Market Size & Forecast
        • 6.4.2.1.1. By Value & Volume
      • 6.4.2.2. Market Share & Forecast
        • 6.4.2.2.1. By Polymer Type
        • 6.4.2.2.2. By Application
    • 6.4.3. Canada Biopharma Plastics Market Outlook
      • 6.4.3.1. Market Size & Forecast
        • 6.4.3.1.1. By Value & Volume
      • 6.4.3.2. Market Share & Forecast
        • 6.4.3.2.1. By Polymer Type
        • 6.4.3.2.2. By Application

7. Europe Biopharma Plastics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Polymer Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Pricing Analysis
  • 7.4. Europe: Country Analysis
    • 7.4.1. France Biopharma Plastics Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value & Volume
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Polymer Type
        • 7.4.1.2.2. By Application
    • 7.4.2. Germany Biopharma Plastics Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value & Volume
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Polymer Type
        • 7.4.2.2.2. By Application
    • 7.4.3. United Kingdom Biopharma Plastics Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value & Volume
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Polymer Type
        • 7.4.3.2.2. By Application
    • 7.4.4. Spain Biopharma Plastics Market Outlook
      • 7.4.4.1. Market Size & Forecast
        • 7.4.4.1.1. By Value & Volume
      • 7.4.4.2. Market Share & Forecast
        • 7.4.4.2.1. By Polymer Type
        • 7.4.4.2.2. By Application
    • 7.4.5. Italy Biopharma Plastics Market Outlook
      • 7.4.5.1. Market Size & Forecast
        • 7.4.5.1.1. By Value & Volume
      • 7.4.5.2. Market Share & Forecast
        • 7.4.5.2.1. By Polymer Type
        • 7.4.5.2.2. By Application

8. Asia-Pacific Biopharma Plastics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Polymer Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Pricing Analysis
  • 8.4. Asia-Pacific: Country Analysis
    • 8.4.1. China Biopharma Plastics Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value & Volume
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Polymer Type
        • 8.4.1.2.2. By Application
    • 8.4.2. India Biopharma Plastics Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value & Volume
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Polymer Type
        • 8.4.2.2.2. By Application
    • 8.4.3. South Korea Biopharma Plastics Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value & Volume
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Polymer Type
        • 8.4.3.2.2. By Application
    • 8.4.4. Japan Biopharma Plastics Market Outlook
      • 8.4.4.1. Market Size & Forecast
        • 8.4.4.1.1. By Value & Volume
      • 8.4.4.2. Market Share & Forecast
        • 8.4.4.2.1. By Polymer Type
        • 8.4.4.2.2. By Application
    • 8.4.5. Indonesia Biopharma Plastics Market Outlook
      • 8.4.5.1. Market Size & Forecast
        • 8.4.5.1.1. By Value & Volume
      • 8.4.5.2. Market Share & Forecast
        • 8.4.5.2.1. By Polymer Type
        • 8.4.5.2.2. By Application

9. South America Biopharma Plastics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Polymer Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Pricing Analysis
  • 9.4. South America: Country Analysis
    • 9.4.1. Brazil Biopharma Plastics Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value & Volume
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Polymer Type
        • 9.4.1.2.2. By Application
    • 9.4.2. Argentina Biopharma Plastics Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value & Volume
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Polymer Type
        • 9.4.2.2.2. By Application

10. Middle East and Africa Biopharma Plastics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Polymer Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. Pricing Analysis
  • 10.4. MEA: Country Analysis
    • 10.4.1. South Africa Biopharma Plastics Market Outlook
      • 10.4.1.1. Market Size & Forecast
        • 10.4.1.1.1. By Value & Volume
      • 10.4.1.2. Market Share & Forecast
        • 10.4.1.2.1. By Polymer Type
        • 10.4.1.2.2. By Application
    • 10.4.2. Saudi Arabia Biopharma Plastics Market Outlook
      • 10.4.2.1. Market Size & Forecast
        • 10.4.2.1.1. By Value & Volume
      • 10.4.2.2. Market Share & Forecast
        • 10.4.2.2.1. By Polymer Type
        • 10.4.2.2.2. By Application
    • 10.4.3. UAE Biopharma Plastics Market Outlook
      • 10.4.3.1. Market Size & Forecast
        • 10.4.3.1.1. By Value & Volume
      • 10.4.3.2. Market Share & Forecast
        • 10.4.3.2.1. By Polymer Type
        • 10.4.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
    • 11.1.1. Increase in healthcare expenditure
    • 11.1.2. Rising cases of cancerous patients
    • 11.1.3. Technological advancement in healthcare
  • 11.2. Challenges
    • 11.2.1. Fluctuation in Raw Material prices
    • 11.2.2. Stringent Government regulations

12. Market Trends & Developments

  • 12.1. Product Launches
  • 12.2. Mergers & Acquisitions
  • 12.3. Technological Advancements

13. Global Biopharma Plastics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Types

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Type Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (In Case of Listed Companies)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1. BASF SE
    • 15.6.2. Spectrum Plastics Group
    • 15.6.3. Celanese Corporation
    • 15.6.4. LyondellBasell Industries Holdings B.V.
    • 15.6.5. DuPont de Nemours, Inc.
    • 15.6.6. Tekni-Plex, Inc.
    • 15.6.7. Solvay S.A.
    • 15.6.8. Avantor, Inc.
    • 15.6.9. Bormioli Pharma S.p.A.
    • 15.6.10. Saudi Basic Industries Corporation

16. Strategic Recommendations